Does CANRENONE Cause Off label use? 18 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 18 reports of Off label use have been filed in association with CANRENONE. This represents 6.3% of all adverse event reports for CANRENONE.
18
Reports of Off label use with CANRENONE
6.3%
of all CANRENONE reports
10
Deaths
15
Hospitalizations
How Dangerous Is Off label use From CANRENONE?
Of the 18 reports, 10 (55.6%) resulted in death, 15 (83.3%) required hospitalization.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CANRENONE. However, 18 reports have been filed with the FAERS database.
What Other Side Effects Does CANRENONE Cause?
Hyperkalaemia (68)
Hyponatraemia (35)
Hypotension (33)
Sopor (25)
Dehydration (24)
Syncope (23)
Drug interaction (21)
Bradycardia (19)
Drug ineffective (19)
Renal failure (19)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which CANRENONE Alternatives Have Lower Off label use Risk?
CANRENONE vs CANTHARIDIN
CANRENONE vs CAPECITABINE
CANRENONE vs CAPIVASERTIB
CANRENONE vs CAPLACIZUMAB
CANRENONE vs CAPLACIZUMAB-YHDP